Unraveling depression in Parkinson's disease.
Antonini
A
A
D000928:Antidepressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D052160:Benzothiazoles / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003863:Depression / Q000188:drug therapy / Q000209:etiology*; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology; D004298:Dopamine / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D015337:Multicenter Studies as Topic; D010300:Parkinson Disease / Q000188:drug therapy / Q000523:psychology*; D000077487:Pramipexole; D011788:Quality of Life; D012701:Serotonin / Q000378:metabolism; D020280:Sertraline / Q000494:pharmacology / Q000627:therapeutic use
D000928:Antidepressive Agents; D052160:Benzothiazoles; D018491:Dopamine Agonists; D012701:Serotonin; D000077487:Pramipexole; D020280:Sertraline; D004298:Dopamine